We are live on ! Find out more
ORI

Oak Ridge Investments Portfolio holdings

AUM $1.77B
1-Year Est. Return 63.16%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+63.16%
3 Year Est. Return
+207.98%
5 Year Est. Return
+285.85%
10 Year Est. Return
+1,406.08%
AUM
$1.81B
AUM Growth
+$46.7M
Cap. Flow
-$117M
Cap. Flow %
-6.44%
Top 10 Hldgs %
23.31%
Holding
167
New
11
Increased
22
Reduced
127
Closed
6

Top Buys

Rank Stock Value
1
PODD icon
Insulet
PODD
+$12.3M
2
EVH icon
Evolent Health
EVH
+$9.38M
3
CBM
Cambrex Corporation
CBM
+$9.24M
4
ARWR icon
Arrowhead Research
ARWR
+$6.23M
5
NOMD icon
Nomad Foods
NOMD
+$5.88M

Sector Composition

Rank Sector Weight
1 Technology 23.84%
2 Healthcare 21.94%
3 Industrials 14.87%
4 Consumer Discretionary 13.92%
5 Consumer Staples 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.96B
$58.1M 3.21%
339,272
-23,221
-6% -$3.5M
AAPL icon
2
Apple
AAPL
$4.95T
$57.6M 3.18%
1,020,668
-56,576
-5% -$2.95M
EPAM icon
3
EPAM Systems
EPAM
$4.92B
$46.8M 2.58%
339,732
-24,812
-7% -$3.34M
MSFT icon
4
Microsoft
MSFT
$2.89T
$45M 2.48%
393,304
-22,933
-6% -$2.49M
AMZN icon
5
Amazon
AMZN
$2.49T
$44.4M 2.45%
442,960
-26,540
-6% -$2.5M
GMED icon
6
Globus Medical
GMED
$10.6B
$43.6M 2.41%
767,540
-58,885
-7% -$3.1M
OMCL icon
7
Omnicell
OMCL
$1.89B
$34.2M 1.89%
475,488
-41,134
-8% -$2.59M
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$34.1M 1.88%
241,099
-18,729
-7% -$2.89M
WEX icon
9
WEX
WEX
$6.17B
$29.3M 1.62%
146,085
-14,168
-9% -$2.72M
POOL icon
10
Pool Corp
POOL
$6.73B
$29.3M 1.62%
175,643
-15,213
-8% -$2.46M
OLLI icon
11
Ollie's Bargain Outlet
OLLI
$4.04B
$28.7M 1.59%
298,993
-26,528
-8% -$2.12M
FIVE icon
12
Five Below
FIVE
$11.5B
$28.3M 1.56%
217,385
-20,635
-9% -$2.3M
WCN
13
Waste Connections
WCN
$42.7B
$28M 1.54%
350,644
-18,286
-5% -$1.44M
FTNT icon
14
Fortinet
FTNT
$112B
$27.5M 1.52%
1,487,805
-239,710
-14% -$3.67M
UNH icon
15
UnitedHealth
UNH
$379B
$26.7M 1.47%
100,261
-5,576
-5% -$1.45M
BURL icon
16
Burlington
BURL
$22.5B
$26.6M 1.47%
163,305
-17,879
-10% -$2.85M
V icon
17
Visa
V
$689B
$26.2M 1.44%
174,338
-9,437
-5% -$1.34M
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$3.99T
$22.4M 1.24%
371,180
-17,860
-5% -$1.08M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$3.99T
$22.3M 1.23%
373,440
-18,860
-5% -$1.13M
WSO icon
20
Watsco Inc
WSO
$15B
$22.3M 1.23%
125,094
-10,018
-7% -$1.77M
ROST icon
21
Ross Stores
ROST
$78.1B
$19.3M 1.07%
195,251
-11,369
-6% -$1.04M
EFOR
22
Everforth Inc
EFOR
$884M
$19.1M 1.05%
242,038
-22,070
-8% -$1.91M
ENV
23
DELISTED
ENVESTNET, INC.
ENV
$18.7M 1.03%
306,936
-34,599
-10% -$2.09M
EEFT icon
24
Euronet Worldwide
EEFT
$3.01B
$18.3M 1.01%
182,836
-14,368
-7% -$1.35M
BFAM icon
25
Bright Horizons
BFAM
$4.1B
$18.2M 1%
154,397
-19,814
-11% -$2.24M

Similar funds

Oak Ridge Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oak Ridge Investments held 167 positions worth $1.81B, up 2.6% from $1.76B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oak Ridge Investments withdrew a net $117M in Q3 2018, closing 6 positions and reducing 127 holdings. Its most notable exit was NEVRO CORP., an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oak Ridge Investments opened a new position in Insulet worth $13.9M.

  • Oak Ridge Investments's largest Q3 2018 buy was Insulet: 130,935 shares worth $13.9M.
  • Oak Ridge Investments added most to Nomad Foods in Q3 2018, an estimated $5.88M increase.
  • Oak Ridge Investments's biggest Q3 2018 reduction was Sarepta Therapeutics, cutting an estimated $10.6M.
  • Oak Ridge Investments fully exited NEVRO CORP. in Q3 2018, selling an estimated $18.3M.
  • Oak Ridge Investments's ten largest holdings make up 23% of its $1.81B portfolio in Q3 2018.
  • Oak Ridge Investments opened 11 new positions and closed 6 in Q3 2018.
  • Oak Ridge Investments's portfolio value rose 2.6% quarter-over-quarter to $1.81B.

Based on Oak Ridge Investments's 13F filing for Q3 2018, filed 7 Nov 2018.